HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of lipoteichoic acid on IL-2 and IL-5 release from T lymphocytes in asthma and COPD.

Abstract
Susceptibility to infections with gram-positive bacteria, which are an important trigger of exacerbations, is increased in COPD and asthma. Unraveling the underlying mechanisms may help developing therapeutic strategies to reduce exacerbation rates. The aim of this study was to evaluate the effects of lipoteichoic acid (LTA), a danger signal from gram-positive bacteria, on T cell cytokines related to bacterial infection defense in COPD and asthma. T cell populations within peripheral blood mononuclear cells (PBMCs) were ex-vivo activated towards T(H)2/T(C)2 subtypes and subsequently stimulated with LTA. IL-2 and IL-5 concentrations in cell culture supernatants were measured by ELISA comparative between non-smokers (NS), current smokers without airflow limitation (S), smokers with moderate to severe COPD and mild to moderate asthmatics (A) (each n=10). IL-2 and IL-5 baseline levels were without differences between the cohorts. After T cell activation, IL-2 and IL-5 releases were increased in all cohorts, however, for IL-2 this increase was significantly higher in S and by trend in COPD compared to the other groups. LTA time-dependently suppressed IL-2 release in NS, S and COPD but not in A. LTA reduced IL-5 release in COPD and A but not in NS and S. Summarized, LTA reduces T(H)2/T(C)2 cytokines indicating immunosuppressive effects, which are dysregulated in COPD and asthma. This implies a misguided response to gram-positive bacterial infections, which might help to explain the increased susceptibility to bacterial infections in COPD and asthma.
AuthorsZeynep Mat, Barbara Grensemann, Yakup Yakin, Jürgen Knobloch, Andrea Koch
JournalInternational immunopharmacology (Int Immunopharmacol) Vol. 13 Issue 3 Pg. 284-91 (Jul 2012) ISSN: 1878-1705 [Electronic] Netherlands
PMID22542695 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Elsevier B.V. All rights reserved.
Chemical References
  • IL2 protein, human
  • IL5 protein, human
  • Interleukin-2
  • Interleukin-5
  • Lipopolysaccharides
  • Teichoic Acids
  • lipoteichoic acid
Topics
  • Adult
  • Aged
  • Asthma (complications, immunology)
  • Case-Control Studies
  • Disease Susceptibility
  • Female
  • Gram-Positive Bacteria (immunology, pathogenicity)
  • Gram-Positive Bacterial Infections (etiology, immunology)
  • Humans
  • In Vitro Techniques
  • Interleukin-2 (biosynthesis)
  • Interleukin-5 (biosynthesis)
  • Lipopolysaccharides (immunology, pharmacology)
  • Male
  • Middle Aged
  • Monocytes (immunology)
  • Pulmonary Disease, Chronic Obstructive (complications, immunology)
  • T-Lymphocytes (drug effects, immunology)
  • T-Lymphocytes, Cytotoxic (drug effects, immunology)
  • Teichoic Acids (immunology, pharmacology)
  • Th2 Cells (drug effects, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: